TISSUE DONATION IS CRITICAL TO FIND TREATMENTS! Click here to learn more.
The EHE library includes publications and articles about EHE research and treatments, as well as other relevant topics that are available online. Some articles are free with open access and others require subscription.
If you have an article to add or any questions, please contact us at [email protected].
"Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts"
This consensus paper provides key recommendations on the management of epithelioid hemangioendothelioma (EHE). Recommendations followed a consensus meeting of a multidisciplinary group of experts from different institutions from Europe, North America and Asia, as well as representatives from the ESMO Faculty, EURACAN, PAEDCAN, GENTURIS, EHE UK/US patient advocates and SPAGN. Thank you to Dr. Silvia Stacchiotti for her leadership and guidance of this groundbreaking resource!
"The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments" was published on February 25, 2024, in the scientific journal, Frontiers in Oncology. Amplifying EHE patients' voices from around the world, the survey evaluated data from 129 patient responses from 21 countries. We thank the patients who were able to contribute to this important paper.
Get email alerts about the latest treatments, research advances, and opportunities to get involved.
| Title of Article (click on title to link) | Publication Year | Key Words |
|---|---|---|
| 2026 | quality of life, qualitative research | |
| 2026 | treatment, eribulin, clinical trial | |
| 2025 | case report, sintilimab, pulmonary | |
| 2025 | ||
| 2025 | incidence, prevalence, treatment | |
| 2025 | pulmonary | |
| 2025 | treatment, hepatic | |
| 2025 | model, cell | |
| 2025 | TAZ-CAMTA1, YAP, Hippo pathway | |
| 2025 | YAP1, TFE3 | |
| 2025 | advocacy, drug development, drug repurposing | |
| 2025 | CAMTA1, TFE3, prognosis, risk model | |
| 2025 | Hepatic, case report, imaging | |
| 2025 | case report, sinus | |
| 2025 | case report, hepatic, symptom | |
| 2025 | TEAD, Hippo pathway, drug development, treatment | |
| 2025 | treatment | |
| 2025 | treatment, pazopanib, metastatic | |
| 2025 | hepatic, liver, resection, surgery | |
| 2025 | ultrasound, hepatic, liver, case study | |
| 2025 | liver, hepatic, surgery, robotics | |
| 2025 | treatment | |
| 2025 | CAMTA1 | |
| 2025 | case report | |
| 2025 | case report | |
| 2025 | case report | |
| 2024 | hepatic, liver, retrospective, treatment | |
| 2024 | hepatic, liver, retrospective study | |
| 2024 | retrospective study | |
| 2024 | drug repurposing, treatment | |
| 2024 | biomarker, sirolimus, treatment | |
| 2024 | clinical registry, natural history study | |
| 2024 | endpoint, response, clinical trial | |
| 2024 | pleural, case report, treatment, diagnosis | |
| 2024 | MRI, diagnosis, pathology, hepatic, liver | |
| 2024 | treatment, drug TAZ, CAMTA1 | |
| 2024 | biology, treatment | |
| 2024 | IRE, hepatic, liver, | |
| 2024 | treatment, liver, transplant, sirolimus | |
| 2024 | treatment, case report, immunotherapy | |
| 2024 | ablation, hepatic, liver, treatment, prognosis | |
| 2024 | treatment, trametinib, clinical trial | |
| 2024 | treatment, sirolimus, survey | |
| 2024 | pulmonary, imaging features, CT | |
| 2024 | WWTR1, TFE3, fusion, case report | |
| 2024 | pleura, case report | |
| 2024 | hepatic, liver, ablation, treatment | |
| 2024 | sirolimus, treatment, outcomes | |
| 2023 | hepatic, liver, treatment | |
| 2023 | hepatic, liver | |
| 2023 | TAZ, CAMTA1, fusion | |
| 2023 | YAP, TAZ, TEAD, Hippo Pathway | |
| 2023 | hepatic, liver, diagnosis | |
| 2023 | case report | |
| 2023 | case report | |
| 2023 | case report, hepatic | |
| 2023 | case report, hepatic, lung | |
| 2023 | hepatic, treatment, prognosis, retrospective | |
| 2023 | retrospective, survival, treatment | |
| 2023 | pulmonary, case report | |
| 2023 | liver, hepatic | |
| 2023 | Hippo Pathway, YAP, TAZ, TEAD | |
| 2023 | hepatic, liver, case report | |
| 2023 | pleura, pulmonary, case report | |
| 2023 | retrospective, survival, prognosis | |
| 2023 | incidence, survival | |
| 2023 | TAZ CAMTA1, model system | |
| 2023 | fusion, biomarker, genomics | |
| 2023 | treatment, systemic, Sirolimus, mTOR inhibitor | |
| 2023 | case report, treatment, PD-1 inhibitor | |
| 2023 | treatment, systemic, Sirolimus, mTOR inhibitor | |
| 2023 | case report, pulmonary | |
| 2023 | hepatic, liver, retrospective | |
| 2023 | case report | |
| 2023 | case report, orthopedic, radiotherapy | |
| 2023 | pulmonary, immunotherapy, case report, treatment, diagnosis | |
| 2023 | pulmonary, vessels, metastasis, surgery, case report | |
| 2023 | abstract, diagnosis, case report, bone, PET/CT | |
| 2023 | treatment, gemcitabine, case report | |
| 2023 | CDKN2A, fusion, progression | |
| 2023 | hepatic, liver, treatment, transplant, diagnosis, surgery | |
| 2023 | hepatic, liver, diagnosis, treatment, case report | |
| 2022 | mediastinal, case report, YAP, TFE3 | |
| 2022 | hepatic, liver, treatment | |
| 2022 | hepatic, liver, ultrasound, retrospective, abstract | |
| 2022 | hepatic, liver, treatment | |
| 2022 | TAZ, YAP, fusion, TEAD | |
| 2022 | hepatic, liver, treatment, transplant, diagnosis, surgery | |
| 2022 | liver, lung, surgery, treatment, metastasis, case report | |
| 2022 | pleura, case report | |
| 2022 | pleura, case report | |
| 2022 | Interferon-Alpha 2b, sirolimus, case report, hepatic, liver, treatment | |
| 2022 | Interferon-Alpha 2b, case report, hepatic, liver, treatment | |
| 2022 | hepatic, surgery, treatment | |
| 2022 | pediatric, treatment, retrospective | |
| 2022 | treatment | |
| 2022 | TAZ, CAMTA1, fusion | |
| 2022 | treatment, liver, hepatic | |
| 2022 | fusion, TAZ, CAMTA1 | |
| 2022 | pleura, metastatic, treatment | |
| 2022 | fusion, YAP, TAZ | |
| 2022 | genomics | |
| 2022 | YAP, TAZ, TEAD | |
| 2022 | fusion, CAMTA1 | |
| 2022 | YAP, TAZ, TEAD | |
| 2022 | liver, hepatic, radiology | |
| 2022 | liver, treatment | |
| 2021 | indolent, treatment, retrospective | |
| 2021 | bone, case report | |
| 2021 | hepatic, liver, treatment, retrospective | |
| 2021 | hepatic, liver, treatment | |
| 2021 | prevalence | |
| 2021 | staging, diagnosis, PET/CT | |
| 2021 | pleura, case report | |
| 2021 | case report, bone, aggressive | |
| 2021 | case report, penis | |
| 2021 | pleura, treatment | |
| 2021 | fusion, YAP | |
| 2021 | fusion, YAP | |
| 2021 | fusion, TAZ, CAMTA1 | |
| 2021 | clinical trial | |
| 2021 | hepatic, treatment | |
| 2021 | symptoms | |
| 2021 | fusion, YAP, TAZ, CAMTA1 | |
| 2021 | fusion, YAP, TAZ, CAMTA1 | |
| 2021 | treatment | |
| 2021 | liver, hepatic, resection, surgery | |
| 2021 | diagnosis, treatment, survival | |
| 2021 | bone, survival | |
| 2021 | bone, treatment | |
| 2021 | survival, prognosis | |
| 2021 | fusion, YAP | |
| 2021 | case report | |
| 2021 | bone, treatment | |
| 2020 | hepatic, liver, treatment, diagnosis | |
| 2020 | lung, treatment, survival, CT, retrospective, abstract | |
| 2020 | hepatic, liver, diagnosis, treatment | |
| 2020 | pulmonary, treatment | |
| 2020 | fusion | |
| 2020 | liver, heptaic, treatment | |
| 2020 | fusion, YAP, TAZ, CAMTA1 | |
| 2020 | treatment | |
| 2020 | treatment, diagnosis | |
| 2020 | treatment | |
| 2020 | survival, prognosis | |
| 2020 | YAP, TAZ, survival, statin | |
| 2020 | symptoms | |
| 2020 | treatment, pediatric | |
| 2020 | treatment | |
| 2020 | diagnosis | |
| 2020 | pulmonary, treatment | |
| 2019 | hepatic, liver, treatment | |
| 2019 | pediatric, survival | |
| 2019 | treatment, surgery, ablation | |
| 2019 | bone, spine | |
| 2019 | pediatric, radiology | |
| 2019 | liver, hepatic, PET | |
| 2019 | bone | |
| 2019 | fusion, CAMTA1 | |
| 2019 | hepatic, liver, transplant | |
| 2019 | treatment | |
| 2018 | hepatic, liver, diagnosis, pathology | |
| 2018 | bone | |
| 2018 | liver, hepatic | |
| 2018 | liver, hepatic, ablation | |
| 2018 | liver, hepatic | |
| 2018 | liver, transplant, hepatic, PET | |
| 2018 | treatment, prognosis | |
| 2018 | resection, surgery | |
| 2018 | bone, spine | |
| 2018 | treatment | |
| 2018 | fusion, YAP, TAZ | |
| 2017 | TFE3, case report | |
| 2017 | lung, pulmonary | |
| 2017 | lung, pleura, pulmonary, PET | |
| 2017 | bone, spine | |
| 2017 | bone, spine | |
| 2017 | lung, pulmonary | |
| 2017 | liver, hepatic, transplant, treatment | |
| 2017 | retrospective | |
| 2016 | CT, PET, prognosis, pulmonary, thoracic, retrospective | |
| 2016 | CAMTA1, fusion | |
| 2016 | treatment, retrospective | |
| 2016 | fusion, TAZ, CAMTA1 | |
| 2016 | liver, hepatic, resection, surgery | |
| 2016 | fusion, YAP, CAMTA1 | |
| 2016 | case report | |
| 2015 | fusion | |
| 2015 | lung, pulmonary, treatment | |
| 2015 | advocate perspective | |
| 2014 | spine, treatment | |
| 2014 | lung, pulmonary, treatment | |
| 2014 | liver, hepatic, treatment | |
| 2014 | fusion, YAP, TAZ, diagnosis | |
| 2014 | diagnosis, treatment, survival, symptoms | |
| 2014 | liver, transplant, hepatic | |
| 2014 | lung, pulmonary | |
| 2014 | bone, spine | |
| 2014 | bone, treatment | |
| 2013 | liver, hepatic, treatment | |
| 2013 | lung, pulmonary, treatment, | |
| 2013 | clinical trial | |
| 2013 | fusion, YAP | |
| 2013 | liver, heptatic, treatment, IRE | |
| 2013 | clinical trial | |
| 2012 | lung, pulmonary | |
| 2012 | bone | |
| 2012 | liver, survival, treatment | |
| 2011 | lung, pulmonary, PET | |
| 2011 | bone | |
| 2011 | fusion | |
| 2011 | lung, pulmonary | |
| 2011 | fusion, CAMTA1 | |
| 2010 | liver, transplant, hepatic, treatment | |
| 2010 | liver, hepatic, treatment | |
| 2010 | lung, pleura, pulmonary | |
| 2010 | liver, transplant, hepatic | |
| 2010 | VEGF | |
| 2010 | liver, transplant, hepatic, treatment | |
| 2009 | liver, hepatic, treatment, retrospective | |
| 2008 | retrospective, prognosis | |
| 2008 | liver, hepatic | |
| 2007 | treatment | |
| 2007 | liver, hepatic, transplant | |
| 2006 | liver, hepatic, transplant, surgery | |
| 2006 | pulmonary, survival, case report | |
| 2004 | liver, hepatic, pediatric | |
| 2003 | bone | |
| 1999 | hepatic, liver | |
| 1999 | liver, transplant, hepatic, resection, surgery | |
| 1995 | liver, transplant, hepatic, survival | |
| 1982 | diagnosis | |
| 2015 | fusion, CAMTA1, diagnosis |